181 related articles for article (PubMed ID: 38493128)
1. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
[TBL] [Abstract][Full Text] [Related]
2. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer.
Shi L; Zhu W; Huang Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
Clin Transl Med; 2022 Jul; 12(7):e989. PubMed ID: 35857905
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
6. The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner.
Li F; Zhao S; Guo T; Li J; Gu C
Biomed Res Int; 2019; 2019():2585743. PubMed ID: 31119158
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer.
Wei W; Dong Z; Gao H; Zhang YY; Shao LH; Jin LL; Lv YH; Zhao G; Shen YN; Jin SZ
Gene; 2019 Aug; 710():178-185. PubMed ID: 31158449
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic
Ikemori R; Gabasa M; Duch P; Vizoso M; Bragado P; Arshakyan M; Luis IC; Marín A; Morán S; Castro M; Fuster G; Gea-Sorli S; Jauset T; Soucek L; Montuenga LM; Esteller M; Monsó E; Peinado VI; Gascon P; Fillat C; Hilberg F; Reguart N; Alcaraz J
Cancer Res; 2020 Jan; 80(2):276-290. PubMed ID: 31694906
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21
Niu H; Huang Y; Yan L; Zhang L; Zhao M; Lu T; Yang X; Chen Z; Zhan C; Shi Y; Wang Q
Int J Biol Sci; 2020; 16(6):1010-1022. PubMed ID: 32140069
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.
Luo M; Luo Y; Mao N; Huang G; Teng C; Wang H; Wu J; Liao X; Yang J
Cell Physiol Biochem; 2018; 51(1):315-336. PubMed ID: 30453281
[TBL] [Abstract][Full Text] [Related]
11. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition.
Tang PC; Chung JY; Xue VW; Xiao J; Meng XM; Huang XR; Zhou S; Chan AS; Tsang AC; Cheng AS; Lee TL; Leung KT; Lam EW; To KF; Tang PM; Lan HY
Adv Sci (Weinh); 2022 Jan; 9(1):e2101235. PubMed ID: 34791825
[TBL] [Abstract][Full Text] [Related]
12. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
13. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
14. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
16. Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.
Pernía O; Belda-Iniesta C; Pulido V; Cortes-Sempere M; Rodriguez C; Vera O; Soto J; Jiménez J; Taus A; Rojo F; Arriola E; Rovira A; Albanell J; Macías MT; de Castro J; Perona R; Ibañez de Caceres I
Epigenetics; 2014 Nov; 9(11):1446-53. PubMed ID: 25482372
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
Yang J; Qin G; Luo M; Chen J; Zhang Q; Li L; Pan L; Qin S
Cell Death Dis; 2015 Jul; 6(7):e1829. PubMed ID: 26203858
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.
Sun B; Hu N; Cong D; Chen K; Li J
Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345
[TBL] [Abstract][Full Text] [Related]
19. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
Jiang LP; He CY; Zhu ZT
Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]